Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
50,088,303
-
Share change
-
+1,417,604
-
Total reported value
-
$7,125,707,525
-
Put/Call ratio
-
72%
-
Price per share
-
$142.56
-
Number of holders
-
407
-
Value change
-
+$206,804,403
-
Number of buys
-
206
-
Number of sells
-
199
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2019
As of 30 Jun 2019,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
407 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,088,303 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FMR LLC, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, NUVEEN ASSET MANAGEMENT, LLC, STATE STREET CORP, Boston Partners, PUTNAM INVESTMENTS LLC, and LSV ASSET MANAGEMENT.
This page lists
408
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.